Looks like J&J will largely ignore anything that is Lifescan related during the Consumer and Med Device business Review on Wednesday. The diabetes topic is not listed on the agenda and short of opening remarks in the Med Device session, it will likely not be addressed. It might be fun to heckle from the crowd if anyone is in attendance with a timely question about the pending offer from Platinum, but that will likely be the only mention if they would even comment on it.

The agenda can be found on the investors portion of the J&J site for any that wish to review it.

click on the agenda listed for the May 16th, event